Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   EV/EBIT(x) 27.2920.9934.669.8510.72

What is the latest EV/EBIT ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EV/EBIT ratio of SYNCOM FORMULATIONS (INDIA) is 27.29 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202427.29
Mar202320.99
Mar202234.66
Mar20179.85
Mar201610.72

How is EV/EBIT of SYNCOM FORMULATIONS (INDIA) Trending?

Years EV/EBIT % Change
Mar2024 27.29
30.01
Mar2023 20.99
-39.44
Mar2022 34.66
251.88
Mar2017 9.85
-8.12
Mar2016 10.72 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EV/EBIT ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,621.5 Cr -5.7% -8.5% 12.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-5.7%

-8.5%

12.1%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses